Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Robin E Clark PhD

    TitleAssociate Professor
    InstitutionUniversity of Massachusetts Medical School
    DepartmentFamily Medicine and Community Health
    AddressUniversity of Massachusetts Medical School
    333 South Street
    Shrewsbury MA 01545
    Phone508-856-4226
      Other Positions
      InstitutionUMMS - School of Medicine
      DepartmentQuantitative Health Sciences

      InstitutionUMMS - Graduate School of Biomedical Sciences
      DepartmentClinical Population Health Research

      InstitutionUMMS - Graduate School of Biomedical Sciences
      DepartmentMD/PhD Program

      InstitutionUMMS - Programs, Centers and Institutes
      DepartmentCenter for Health Policy and Research

        Overview 
        Narrative

        Robin Clark is Senior Director of Research and Evaluation at the Center for Health Policy and Research. Dr. Clark specializes in the economic evaluation of health care interventions and policies, primarily those related to mental health and substance abuse. His work has been funded by the National Institute of Mental Health, the National Institute on Drug Abuse, the Robert Wood Johnson Foundation and by health and human services agencies in all of the New England states.

         

        His current work focuses on efforts to manage costs and improve the quality and effectiveness of care for individuals with chronic illness, with a particular focus on Medicaid beneficiaries and other underserved populations. Clark’s research includes analyses of treatment patterns and costs for severe mental illness and substance use disorders, the link between substance use disorders and quality of care for various chronic health conditions and the impact of medication assisted treatment on outcomes and costs of treatment for opioid addiction.



        Bibliographic 
        selected publications
        List All   |   Timeline
        1. Clark RE, Baxter JD. Responses of state Medicaid programs to buprenorphine diversion: Doing more harm than good?. JAMA Internal Medicine. 2013; 17(173):1571-1572.
        2. Mueser KT, Glynn SM, Cather C, Xie H, Zarate R, Smith LF, Clark RE, Gottlieb JD, Wolfe R, Feldman J. A Randomized Controlled Trial of Family Intervention for Co-occurring Substance Use and Severe Psychiatric Disorders. Schizophr Bull. 2013 May; 39(3):658-72.
          View in: PubMed
        3. Weir S, Posner HE, Jones WC, Willis G, Baxter JD, Clark RE. Disparities in routine breast cancer screening for medicaid managed care members with a work-limiting disability. Medicare Medicaid Res Rev. 2011; 1(4).
          View in: PubMed
        4. Lin WC, Zhang J, Leung GY, Clark RE. Twelve-month diagnosed prevalence of behavioral health disorders among elderly medicare and medicaid members. Am J Geriatr Psychiatry. 2011 Nov; 19(11):970-9.
          View in: PubMed
        5. Lin WC, Zhang J, Leung GY, Clark RE. Chronic Physical Conditions in Older Adults with Mental Illness and/ or Substance Use Disorders. J Am Geriatr Soc. 2011 Oct; 59(10):1913-21.
          View in: PubMed
        6. Clark RE, Samnaliev M, Baxter JD, Leung GY. The Evidence Doesn't Justify Steps By State Medicaid Programs To Restrict Opioid Addiction Treatment With Buprenorphine. Health Aff (Millwood). 2011 Aug; 30(8):1425-33.
          View in: PubMed
        7. Leung G, Zhang J, Lin WC, Clark RE. Behavioral disorders and diabetes-related outcomes among massachusetts medicare and medicaid beneficiaries. Psychiatr Serv. 2011 Jun; 62(6):659-65.
          View in: PubMed
        8. Weir S, Posner HE, Zhang J, Willis G, Baxter JD, Clark RE. Predictors of prenatal and postpartum care adequacy in a medicaid managed care population. Womens Health Issues. 2011 Jul-Aug; 21(4):277-85.
          View in: PubMed
        9. Baxter JD, Clark RE, Samnaliev M, Leung GY, Hashemi L. Factors associated with Medicaid patients' access to buprenorphine treatment. J Subst Abuse Treat. 2011 Jul; 41(1):88-96.
          View in: PubMed
        10. Leung GY, Zhang J, Lin WC, Clark RE. Behavioral health disorders and adherence to measures of diabetes care quality. Am J Manag Care. 2011 Feb; 17(2):144-50.
          View in: PubMed
        11. Clark RE, Weir S, Ouellette RA, Zhang J, Baxter JD. Beyond health plans: behavioral health disorders and quality of diabetes and asthma care for Medicaid beneficiaries. Med Care. 2009 May; 47(5):545-52.
          View in: PubMed
        12. Mueser KT, Glynn SM, Cather C, Zarate R, Fox L, Feldman J, Wolfe R, Clark RE. Family intervention for co-occurring substance use and severe psychiatric disorders: participant characteristics and correlates of initial engagement and more extended exposure in a randomized controlled trial. Addict Behav. 2009 Oct; 34(10):867-77.
          View in: PubMed
        13. Samnaliev M, McGovern MP, Clark RE. Racial/ethnic disparities in mental health treatment in six Medicaid programs. J Health Care Poor Underserved. 2009 Feb; 20(1):165-76.
          View in: PubMed
        14. Clark RE, Samnaliev M, McGovern MP. Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disorders. Psychiatr Serv. 2009 Jan; 60(1):35-42.
          View in: PubMed
        15. Baxter JD, Samnaliev M, Clark RE. The quality of asthma care among adults with substance-related disorders and adults with mental illness. Psychiatr Serv. 2009 Jan; 60(1):43-9.
          View in: PubMed
        16. Samnaliev M, Baxter JD, Clark RE. Comparative evaluation of two asthma care quality measures among Medicaid beneficiaries. Chest. 2009 May; 135(5):1193-6.
          View in: PubMed
        17. Baxter JD, Samnaliev M, Clark RE. Patterns of health care utilization for asthma treatment in adults with substance use disorders. J Addict Med. 2008 Jun; 2(2):79-84.
          View in: PubMed
        18. Weir S, Aweh G, Clark RE. Case selection for a Medicaid chronic care management program. Health Care Financ Rev. 2008; 30(1):61-74.
          View in: PubMed
        19. McGovern MP, Clark RE, Samnaliev M. Co-occurring psychiatric and substance use disorders: a multistate feasibility study of the quadrant model. Psychiatr Serv. 2007 Jul; 58(7):949-54.
          View in: PubMed
        20. Clark RE, Samnaliev M, McGovern MP. Treatment for co-occurring mental and substance use disorders in five state Medicaid programs. Psychiatr Serv. 2007 Jul; 58(7):942-8.
          View in: PubMed
        21. Cook JA, Leff HS, Blyler CR, Gold PB, Goldberg RW, Clark RE, Onken SJ, Shafer MS, Blankertz LE, McFarlane WR, Razzano LA, Burke-Miller JK. Estimated payments to employment service providers for persons with mental illness in the Ticket to Work program. Psychiatr Serv. 2006 Apr; 57(4):465-71.
          View in: PubMed
        22. Clark RE, Samnaliev M. Psychosocial treatment in the 21st century. Int J Law Psychiatry. 2005 Sep-Oct; 28(5):532-44.
          View in: PubMed
        23. Mueser KT, Clark RE, Haines M, Drake RE, McHugo GJ, Bond GR, Essock SM, Becker DR, Wolfe R, Swain K. The Hartford study of supported employment for persons with severe mental illness. J Consult Clin Psychol. 2004 Jun; 72(3):479-90.
          View in: PubMed
        24. Clark RE, Xie H, Brunette MF. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness. J Clin Psychiatry. 2004 Feb; 65(2):151-5.
          View in: PubMed
        25. Mellman TA, Clark RE, Peacock WJ. Prescribing patterns for patients with posttraumatic stress disorder. Psychiatr Serv. 2003 Dec; 54(12):1618-21.
          View in: PubMed
        26. Bartels SJ, Clark RE, Peacock WJ, Dums AR, Pratt SI. Medicare and medicaid costs for schizophrenia patients by age cohort compared with costs for depression, dementia, and medically ill patients. Am J Geriatr Psychiatry. 2003 Nov-Dec; 11(6):648-57.
          View in: PubMed
        27. Clark RE, Mueser KT. Progress in research on dual disorders. Br J Psychiatry. 2003 Nov; 183:377-8.
          View in: PubMed
        28. Clark RE, Bartels SJ, Mellman TA, Peacock WJ. Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy. Schizophr Bull. 2002; 28(1):75-84.
          View in: PubMed
        For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
        Robin's Networks
        Click the "See All" links for more information and interactive visualizations!
        Concepts
        _
        Co-Authors
        _
        Similar People
        _
        Same Department
        Physical Neighbors
        _

        This is an official Page/Publication of the University of Massachusetts Worcester Campus
        Office of the Vice Provost for Research, 55 Lake Ave North, Worcester, Massachusetts 01655
        Questions or Comments? Email: publicaffairs@umassmed.edu Phone: 508-856-1572